Home Four Junlin Capital-Backed Firms Named to 2023 'Innovate China' List; IPO Filings Follow

Four Junlin Capital-Backed Firms Named to 2023 'Innovate China' List; IPO Filings Follow

Jul 04, 2024 18:02 CST Updated 18:02
Imunopharm

Developer of Gene and Cell Therapy Technologies